Gabriel Sica

Emory University — United States

Medicine · Health Sciences

67h-index52.9kcitations313works4.12yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(68), Cancer Genomics and Diagnostics(46), Lung Cancer Research Studies(46), Cancer Immunotherapy and Biomarkers(33), RNA modifications and cancer(28)

Publications274 total

Pathologists’ experience and routine practice in high-volume lung transplant centers: An international survey
JHLT Open·2025Open Access
Randomized Phase II Study of Concurrent Versus Sequential Pembrolizumab in Combination With Chemoradiation in Locally Advanced Head and Neck Cancer
Journal of Clinical Oncology·2025· 13 citedOpen Access
Abstract 5804: Pathologic responses to neoadjuvant immune checkpoint inhibitor (ICI) combinations in head and neck squamous cell carcinoma (HNSCC) associate with specific CD4+ helper and regulatory T cell activation states and clonal plasticity
Cancer Research·2025
Distinct CD8+ T cell dynamics associate with response to neoadjuvant cancer immunotherapies
Cancer Cell·2025· 37 citedOpen Access
Uncovering the rewired IAP-JAK regulatory axis as an immune-dependent vulnerability of LKB1-mutant lung cancer
Nature Communications·2025· 3 citedOpen Access
A 40-Year-Old With Prior Stem Cell Transplant for Chronic Myeloid Leukemia Presents With Dyspnea and Respiratory Failure
CHEST Journal·2025Open Access
Polo-like Kinase 1 Inhibitors Demonstrate In Vitro and In Vivo Efficacy in Preclinical Models of Small Cell Lung Cancer
Cancers·2025· 2 citedOpen Access
493 Distinct correlative signatures of CD4<sup>+</sup> helper and regulatory T cells associate with response to different neoadjuvant immune checkpoint inhibitor combinations in HNSCC
Regular and Young Investigator Award Abstracts·2024Open Access
CASTOR1 phosphorylation predicts poor survival in male patients with KRAS-mutated lung adenocarcinoma
Cell & Bioscience·2024· 3 citedOpen Access
Cellular Immune and Genomic Biomarkers in NRG-HN003, a Phase I Study Adding Pembrolizumab to Adjuvant Cisplatin and Radiation Therapy (CRT) in Pathologically High-Risk Head and Neck Cancer (HNSCC)
International Journal of Radiation Oncology*Biology*Physics·2024
CASTOR1 phosphorylation as a predictor of survival in male patients with <i>KRAS</i>-mutated lung adenocarcinoma.
Journal of Clinical Oncology·2024
Abstract 7394: Delineating spatial expression signatures of lung adenocarcinoma subtypes from spatial single-cell transcriptomics using graph neural networks
Cancer Research·2024
NRG-HN003: Phase I and Expansion Cohort Study of Adjuvant Pembrolizumab, Cisplatin and Radiation Therapy in Pathologically High-Risk Head and Neck Cancer with Exploratory Biomarker Correlatives
International Journal of Radiation Oncology*Biology*Physics·2024
Abstract B005: Lymphoid aggregates dictate immune activity in melanoma and lung brain metastases
Cancer Research·2024
Characteristics and anatomic location of PD-1 <sup>+</sup> TCF1 <sup>+</sup> stem-like CD8 T cells in chronic viral infection and cancer
Proceedings of the National Academy of Sciences·2023· 60 citedOpen Access
Molecular and immune signatures, and pathological trajectories of fatal COVID‐19 lungs defined by in situ spatial single‐cell transcriptome analysis
Journal of Medical Virology·2023· 15 citedOpen Access
Early Detection and Staging of Lung Fibrosis Enabled by Collagen-Targeted MRI Protein Contrast Agent
Chemical & Biomedical Imaging·2023· 15 citedOpen Access
Abstract 1752: Darolutamide reverses osimertinib resistance in non-small cell lung cancer
Cancer Research·2023
Data from Rapamycin Induces Bad Phosphorylation in Association with Its Resistance to Human Lung Cancer Cells
2023Open Access
Supplementary Figure 3 from Niclosamide Overcomes Acquired Resistance to Erlotinib through Suppression of STAT3 in Non–Small Cell Lung Cancer
2023Open Access
page 1 of 14Next →

Frequent Co-authors

Suresh S. Ramalingam(23), Fadlo R. Khuri(21), Taofeek K. Owonikoko(20), Xingming Deng(12), Walter J. Curran(11), Zhengjia Chen(9), Rathi N. Pillai(8), Madhusmita Behera(8), Koji Tamada(7), Lieping Chen(7), Dallas B. Flies(6), Gefeng Zhu(6), Dongkyoo Park(6), Michael R. Rossi(6), Guojing Zhang(5), Shi‐Yong Sun(5), Andrew T. Magis(5), Dong M. Shin(5), Alice O. Kamphorst(4), Rafi Ahmed(4)